Daniel Grosslight
Stock Analyst at Citigroup
(1.32)
# 3,710
Out of 5,182 analysts
134
Total ratings
37.5%
Success rate
-11.5%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Initiates: Buy | $145 | $117.87 | +23.02% | 1 | Apr 15, 2026 | |
| PAHC Phibro Animal Health | Initiates: Neutral | $62 | $56.14 | +10.44% | 1 | Apr 15, 2026 | |
| IDXX IDEXX Laboratories | Initiates: Neutral | $650 | $574.95 | +13.05% | 1 | Apr 15, 2026 | |
| HSIC Henry Schein | Initiates: Buy | $100 | $77.20 | +29.53% | 1 | Apr 15, 2026 | |
| NVST Envista Holdings | Initiates: Neutral | $29 | $26.77 | +8.33% | 1 | Apr 15, 2026 | |
| ELAN Elanco Animal Health | Initiates: Buy | $30 | $22.09 | +35.81% | 1 | Apr 15, 2026 | |
| XRAY DENTSPLY SIRONA | Initiates: Sell | $10 | $11.96 | -16.39% | 1 | Apr 15, 2026 | |
| ALGN Align Technology | Initiates: Buy | $240 | $184.70 | +29.94% | 1 | Apr 15, 2026 | |
| PHR Phreesia | Downgrades: Neutral | $25 → $10 | $9.62 | +3.95% | 9 | Mar 31, 2026 | |
| HCAT Health Catalyst | Maintains: Neutral | $2.75 → $1.75 | $1.37 | +27.74% | 13 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $13 → $24 | $29.39 | -18.34% | 14 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $6 | $5.85 | +2.56% | 14 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $32 | $24.41 | +31.09% | 2 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4.5 → $3.5 | $2.28 | +53.51% | 9 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $25.32 | -25.95% | 7 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $3.47 | +15.27% | 7 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $21 | $24.22 | -13.29% | 5 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $35 | $25.70 | +36.19% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $4 | $3.42 | +16.96% | 1 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $190 → $244 | $202.34 | +20.59% | 11 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $820 → $860 | $828.32 | +3.82% | 8 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $1.76 | +468.18% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $9.87 | -18.95% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $0.92 | +36.18% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $5.18 | -32.43% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $13.08 | -0.61% | 1 | Dec 11, 2019 |
Zoetis
Apr 15, 2026
Initiates: Buy
Price Target: $145
Current: $117.87
Upside: +23.02%
Phibro Animal Health
Apr 15, 2026
Initiates: Neutral
Price Target: $62
Current: $56.14
Upside: +10.44%
IDEXX Laboratories
Apr 15, 2026
Initiates: Neutral
Price Target: $650
Current: $574.95
Upside: +13.05%
Henry Schein
Apr 15, 2026
Initiates: Buy
Price Target: $100
Current: $77.20
Upside: +29.53%
Envista Holdings
Apr 15, 2026
Initiates: Neutral
Price Target: $29
Current: $26.77
Upside: +8.33%
Elanco Animal Health
Apr 15, 2026
Initiates: Buy
Price Target: $30
Current: $22.09
Upside: +35.81%
DENTSPLY SIRONA
Apr 15, 2026
Initiates: Sell
Price Target: $10
Current: $11.96
Upside: -16.39%
Align Technology
Apr 15, 2026
Initiates: Buy
Price Target: $240
Current: $184.70
Upside: +29.94%
Phreesia
Mar 31, 2026
Downgrades: Neutral
Price Target: $25 → $10
Current: $9.62
Upside: +3.95%
Health Catalyst
Mar 13, 2026
Maintains: Neutral
Price Target: $2.75 → $1.75
Current: $1.37
Upside: +27.74%
Mar 10, 2026
Upgrades: Neutral
Price Target: $13 → $24
Current: $29.39
Upside: -18.34%
Mar 3, 2026
Maintains: Neutral
Price Target: $9 → $6
Current: $5.85
Upside: +2.56%
Mar 3, 2026
Maintains: Buy
Price Target: $34 → $32
Current: $24.41
Upside: +31.09%
Mar 3, 2026
Maintains: Buy
Price Target: $4.5 → $3.5
Current: $2.28
Upside: +53.51%
Mar 3, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $25.32
Upside: -25.95%
Feb 26, 2026
Maintains: Buy
Price Target: $6 → $4
Current: $3.47
Upside: +15.27%
Feb 25, 2026
Maintains: Buy
Price Target: $63 → $21
Current: $24.22
Upside: -13.29%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $35
Current: $25.70
Upside: +36.19%
Jan 9, 2026
Maintains: Buy
Price Target: $7 → $4
Current: $3.42
Upside: +16.96%
Jan 9, 2026
Upgrades: Buy
Price Target: $190 → $244
Current: $202.34
Upside: +20.59%
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $828.32
Upside: +3.82%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $1.76
Upside: +468.18%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $9.87
Upside: -18.95%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $0.92
Upside: +36.18%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $5.18
Upside: -32.43%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $13.08
Upside: -0.61%